Tan Elaine, Almaraz Ruben T, Khanna Hargun S, Du Jian, Yarema Kevin J
Department of Biomedical Engineering, The Johns Hopkins University, Baltimore, Maryland.
Curr Protoc Chem Biol. 2010 Sep 1;2(3):171-94. doi: 10.1002/9780470559277.ch100059.
Metabolic oligosaccharide engineering (MOE) refers to a technique where non-natural monosaccharide analogs are introduced into living biological systems. Once inside a cell, these compounds intercept a targeted biosynthetic glycosylation pathway and in turn are metabolically incorporated into cell-surface-displayed oligosaccharides where they can modulate a host of biological activities or be exploited as "tags" for bio-orthogonal and chemoselective ligation reactions. Undertaking a MOE experiment can be a daunting task based on the growing repertoire of analogs now available and the ever increasing number of metabolic pathways that can be targeted; therefore, a major emphasis of this article is to describe a general approach for analog design and selection and then provide protocols to ensure safe and efficacious analog usage by cells. Once cell-surface glycans have been successfully remodeled by MOE methodology, the stage is set for probing changes to the myriad cellular responses modulated by these versatile molecules. Curr. Protoc. Chem. Biol. 2:171-194 © 2010 by John Wiley & Sons, Inc.
代谢性寡糖工程(MOE)是指一种将非天然单糖类似物引入活生物系统的技术。一旦进入细胞,这些化合物会拦截目标生物合成糖基化途径,进而代谢性地掺入细胞表面展示的寡糖中,在那里它们可以调节一系列生物活性,或被用作生物正交和化学选择性连接反应的“标签”。基于目前可用的类似物种类不断增加以及可靶向的代谢途径数量不断增多,开展MOE实验可能是一项艰巨的任务;因此,本文的一个主要重点是描述类似物设计和选择的一般方法,然后提供确保细胞安全有效使用类似物的方案。一旦通过MOE方法成功重塑细胞表面聚糖,就为探究这些多功能分子调节的无数细胞反应的变化奠定了基础。《化学与生物学实验指南》第2卷:171 - 194页 版权所有2010年,约翰·威利父子公司。